Question
Explain the clinical significance of Rh antigens in human blood.
Answer :
Word Count : 455
The Rh antigens, particularly the D antigen, are surface proteins present on red blood cells and play a crucial role in transfusion medicine and prenatal care. The presence or absence of these antigens determines an individual's Rh blood group as either Rh-positive or Rh-negative. Clinically, Rh antigens are significant because they can trigger immune responses when an Rh-negative individual is exposed to Rh-positive blood, leading to the production of anti-D antibodies. This immune response is central to several medical conditions, including hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN). In transfusion medicine, compatibility between the donor and recipient's Rh status is essential. If an Rh-negative person receives Rh-positive blood, ________ __________ _________ ___ _________ ____ _________ ________ __________ _______.
____ ________ _________ ___ ______ _______ ___ _____ ____ ________ _________.
________ ___ _______ _______ __________ ___ ___ _____.
__________ ____ _______ ___ _______ _________.
__________ ________ _____ ______ _______.
__________ _____ ________ _________ _______ __________ _______ ________ _____.
___ ________ ______ _____ _______ ________.
_____ ________ ______ __________ _________ ______ ________.
_____ _______ ________ _________ ___ ____ ___ __________ ____ ______ _________ __________.
___ ____ __________ _________ ____ __________.
____ ___ ____ ______ _________ ________ ______ _______ _________.
_______ ________ ______ _________ __________ ________ __________ ________ __________ ___.
___ ____ _______ ______ ___ ______ ____.
_________ ____ _______ _______ ________ ________ ___ ________ _____ _______.
_________ ______ __________ _________ ___ _________ _________ _________ ___.
__________ ______ ___ _________ ____ ______ __________ _________ _______ ____ ___.
________ ____ ________ _______ _________ ___ _____ ______ _____ ______ _______ ________.
_________ ____ _________ ____ __________ _____ ____ ____ _______.
_______ _________ _________ _____ ____ ______ ____ ___ __________ ______.
_____ __________ ____ ________ _____ _______ ___.
___ ____ ____ _____ ______ _____ __________ _____ _______ _________ ______.
______ ______ _________ ____ _________.
________ _____ _______ _____ _____ _____ _____ ________ _____ ___ ______.
___ _______ ______ _________ ______ _____.
_______ __________ ________ ______ ____ ________ ____ __________ ____ ____ _________.
_________ ____ ______ ______ _______ ________ _____ ___.
______ __________ _______ _______ __________ ____ _________ _____.
____ _________ ____ _________ ______ ______ ________ ______ ____ ______ ________.
_____ _________ __________ _______ _____ _____ ___ ________ ____.
____ ___ ____ _____ _____ ________ ________ _____ ____.
______ __________ ____ __________ ______ _______ ________ _______ ____ _____ __________ ___.
___ ________ ________ _______ ___ ________ _____.
____ _____ ________ __________ __________ _____.
_____ ________ _________ ____ ___ ________ __________ __________ ___ ________ _______ __________.
_____ _________ ________ ____ _____.
________ ____ ___ _____ ____ __________ _____ _____.
____ __________ _____ ___ _____ ______.
_________ __________ _________ ___ __________ _____ ____ ___.
______ _____ _____ _____ ___ ______ _____ _____.
_________ __________ _________ ______ ________ _____ ___.
Get Full Answer on WhatsApp
The Rh antigens, particularly the D antigen, are surface proteins present on red blood cells and play a crucial role in transfusion medicine and prenatal care. The presence or absence of these antigens determines an individual's Rh blood group as either Rh-positive or Rh-negative. Clinically, Rh antigens are significant because they can trigger immune responses when an Rh-negative individual is exposed to Rh-positive blood, leading to the production of anti-D antibodies. This immune response is central to several medical conditions, including hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN). In transfusion medicine, compatibility between the donor and recipient's Rh status is essential. If an Rh-negative person receives Rh-positive blood, ________ __________ _________ ___ _________ ____ _________ ________ __________ _______.
____ ________ _________ ___ ______ _______ ___ _____ ____ ________ _________.
________ ___ _______ _______ __________ ___ ___ _____.
__________ ____ _______ ___ _______ _________.
__________ ________ _____ ______ _______.
__________ _____ ________ _________ _______ __________ _______ ________ _____.
___ ________ ______ _____ _______ ________.
_____ ________ ______ __________ _________ ______ ________.
_____ _______ ________ _________ ___ ____ ___ __________ ____ ______ _________ __________.
___ ____ __________ _________ ____ __________.
____ ___ ____ ______ _________ ________ ______ _______ _________.
_______ ________ ______ _________ __________ ________ __________ ________ __________ ___.
___ ____ _______ ______ ___ ______ ____.
_________ ____ _______ _______ ________ ________ ___ ________ _____ _______.
_________ ______ __________ _________ ___ _________ _________ _________ ___.
__________ ______ ___ _________ ____ ______ __________ _________ _______ ____ ___.
________ ____ ________ _______ _________ ___ _____ ______ _____ ______ _______ ________.
_________ ____ _________ ____ __________ _____ ____ ____ _______.
_______ _________ _________ _____ ____ ______ ____ ___ __________ ______.
_____ __________ ____ ________ _____ _______ ___.
___ ____ ____ _____ ______ _____ __________ _____ _______ _________ ______.
______ ______ _________ ____ _________.
________ _____ _______ _____ _____ _____ _____ ________ _____ ___ ______.
___ _______ ______ _________ ______ _____.
_______ __________ ________ ______ ____ ________ ____ __________ ____ ____ _________.
_________ ____ ______ ______ _______ ________ _____ ___.
______ __________ _______ _______ __________ ____ _________ _____.
____ _________ ____ _________ ______ ______ ________ ______ ____ ______ ________.
_____ _________ __________ _______ _____ _____ ___ ________ ____.
____ ___ ____ _____ _____ ________ ________ _____ ____.
______ __________ ____ __________ ______ _______ ________ _______ ____ _____ __________ ___.
___ ________ ________ _______ ___ ________ _____.
____ _____ ________ __________ __________ _____.
_____ ________ _________ ____ ___ ________ __________ __________ ___ ________ _______ __________.
_____ _________ ________ ____ _____.
________ ____ ___ _____ ____ __________ _____ _____.
____ __________ _____ ___ _____ ______.
_________ __________ _________ ___ __________ _____ ____ ___.
______ _____ _____ _____ ___ ______ _____ _____.
_________ __________ _________ ______ ________ _____ ___.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★